작성일 : 15-01-02 16:52
| 연구단계 | 1단계 :1년차 | ||
| 논문제목(영문) | Clinical Impact of High Triglycerides and Central Obesity in Patients with Acute Myocardial Infarction who Underwent Percutaneous Coronary Intervention. | ||
| 국내외구분 | 국내 | SCI여부 | SCI(E) |
| 연구책임자역활 | 교신저자 | 논문기여율 | 30% |
| 주저자명 | Han SG | ||
| 교신저자명 | Jeong MH | ||
| 공동저자명 | Rhee JA, Choi JS, Lee KH, Park KH, Sim DS, Hong YJ, Kim JH, Ahn YK, Cho JG, Park JC, Kang JC. | ||
| 게제년월일 | 2014-02-01 | ||
| ISSN | 1738-9364 | ||
| Impact Factor | 0 | ||
| 학술지명 | Korean J Med | ||
| 서지사항 | 0집 / 86권 / 2호, 페이지(169 - 178) | ||
| 병기표기 | 단독 | ||
| Acknowledgement 기재여부 |
예
※ Acknowledgement가 기재된 논문만 연구과제의 성과로 인정. - 국문 표기 : "본 연구는 보건복지부 보건의료연구개발사업의 지원에 의하여 이루어진 것임. (HI13C1527)" - 영문 표기 : "This study was supported by a grant of the Korean Health Technology R&D Project, (HI13C1527) Ministry of Health & Welfare, Republic of Korea. " |
||
| 요약초록문 (Abstract) 입력 |
BACKGROUND/AIMS: Dyslipidemia and obesity are risk factors for the development of acute myocardial infarction (AMI) that affect the clinical outcomes in patients. METHODS: We analyzed 2,751 consecutive AMI patients who underwent percutaneous coronary intervention (PCI) (mean age, 63.7 +/- 12.1 years). The patients were divided into four groups based on serum triglyceride levels and central obesity [Group Ia: triglycerides < 200 mg/dL and (-) central obesity; Group Ib: triglyceride < 200 mg/dL and (+) central obesity; Group IIa: triglyceride > or = 200 mg/dL and (-) central obesity; Group IIb: triglyceride > or = 200 mg/dL and (+) central obesity]. In-hospital outcome was defined as in-hospital mortality and complications. One-year clinical outcome was compared and defined as the composite of 1-year major adverse cardiac events (MACE), including death, recurrent MI, and target vessel revascularization. RESULTS: Total MACE developed in 502 patients (18.2%), while 303 patients (11.0%) died prior to the 1-year follow-up visit. In-hospital complications and in-hospital mortality were not different among the four groups. One-year clinical outcomes based on triglyceride levels (Group I vs. Group II) were not different. In addition, there were no differences in clinical outcomes in patients with a triglyceride level < 200 mg/dL, regardless of central obesity. One-year MACE rates were not significantly different among the four groups. CONCLUSIONS: There was no significant difference in the 1-year MACE rate based on the triglyceride level and presence of central obesity in patients with AMI who underwent PCI. |
||
Total 9
|
